Original language | English (US) |
---|---|
Pages (from-to) | 133-136 |
Number of pages | 4 |
Journal | Immunology Today |
Volume | 4 |
Issue number | 5 |
DOIs | |
State | Published - May 1983 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Immunology Today, Vol. 4, No. 5, 05.1983, p. 133-136.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Whatever happed to the industry I was told to distrust?
AU - Poste, George
N1 - Funding Information: When I was approached three years ago about moving to industry, I had never considered this as a possible career option. My career in academia had made steady and satisfying progress to a full professorship, my research was well funded by grant agencies and I was in the final stage of negotiating a departmental chairmanship. Like many in academia, I had a long list of preconceptions about industry, many of which were unflatter- ing. Distrust of industry and its motives were common in all of the academic centers in which I worked for 14 years (the term industry as used here refers to the entire private sector from abaca farming to zirconium welding and not to any single industry). These negative attitudes still persist in many sectors of academia and few in academia are left untouched by a doctrinaire vision of corporate philistinism. I was no excep- tion and uncritically accepted the popular opinion that industry did not offer a suitable environment for first- class scientific research and that in- dustrial research in general was inferior to that done in academia. My cynicism about industrial research began to change during a series of exploratory interviews which followed the invitation to move to industry. My exposure to the extraordinary resources, rapid pace and technical sophistication of industrial research led to a growing respect for industrial research and a better apprecia- tion of the opportunities that industry seemed to offer in meeting the challenge of biomedical research in the 1980s. My impressions of industry are limit- ed to a short period in one company - a large, multinational pharmaceutical company. Although my own reaction to working in industry is enormously pos- itive, I am uncertain as to how far my experiences are typical. Indeed, I suspect that they are not and different companies may have very different attitudes towards research depending on their re- sources, financial status, commercial goals and, as in every environment, the people involved. I have been particularly fortunate for several reasons. The company I joined was enjoying the fruits of several years of significant growth and high profitability and was keen to rein- vest heavily in research and development (R and D) to ensure its long-term com- petitiveness. As the new Director of Research, I was afforded significant re- sources to strengthen existing programs and to establish new programs in cell
PY - 1983/5
Y1 - 1983/5
UR - http://www.scopus.com/inward/record.url?scp=48749149860&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=48749149860&partnerID=8YFLogxK
U2 - 10.1016/0167-5699(83)90062-2
DO - 10.1016/0167-5699(83)90062-2
M3 - Article
AN - SCOPUS:48749149860
SN - 0167-5699
VL - 4
SP - 133
EP - 136
JO - Immunology Today
JF - Immunology Today
IS - 5
ER -